Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant LH Supplementation to Recombinant FSH During the Final Days of Controlled Ovarian Stimulation for IVF: a Multicentre, Prospective, Randomized, Controlled Trial

NCT00553293 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT00553293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00553293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant LH Supplementation to Recombinant FSH During the Final Days of Controlled Ovarian Stimulation for IVF: a Multicentre, Prospective, Randomized, Controlled Trial
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2003
Completion date
November 30, 2004
Enrollment
526 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

in vitro fertilization, infertility